Special reports Archives - Parkinson's Life

Special reports

In the second in our series, we explore the debate
READ MORE
Special reports

We explore the debate surrounding Parkinson’s and animal testing
READ MORE
Special reports

More than 7300 male veterans took part in the study
READ MORE

Parkinson’s and animal testing: the case against

In the second in our series, we explore the debate

Do we have the right to test Parkinson’s medications on animals?

We explore the debate surrounding Parkinson’s and animal testing

Age, smoking and lack of fitness increase risk of Parkinson’s

More than 7300 male veterans took part in the study

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

A single head injury could increase risk of Parkinson’s

A study has found a link between head injuries and Parkinson’s

woman talking with business colleagues in office

STEP – The lived experience of Parkinson’s disease

STEP™ hopes to give a voice to people living with Parkinson’s

Crowded sidewalk on Oxford Street in London

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

Neurological disorders – including Parkinson’s – are leading source of disability globally

Parkinson’s is world’s fastest growing neurological disorder

£16,000 a year: the hidden price of Parkinson’s

Research reveals the monetary cost of Parkinson’s for UK families

Muhammad Ali’s death “has raised Parkinson’s awareness”

Muhammad Ali’s legacy lives on

How close are we to a Parkinson’s breakthrough? Three experts have their say

Renowned experts give their opinions on the next breakthrough

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

Dogs have been trained to sniff out Parkinson’s disease

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

“We cannot gather too much data”

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Parkinson’s patients “too afraid” to reveal diagnosis

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Second Life: a (virtual) world without Parkinson’s

Are we too focused on the search for a Parkinson’s cure?

We ask Parkinson’s experts for their views on this controversial debate

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Shedding light on the dementia often mistaken for Parkinson’s

“Brain Surgery Live is a modern medical miracle the public deserved to see”

Exposure for such modern miracles is crucial, argues Justin Rossi

The future generation of advanced therapies for Parkinson’s

Dr Kieran Breen explores the potential of stem cell & gene therapies

Neurologists should be ‘guides not gods’ – Part 2

Top expert Bastiaan Bloem argues the case for a more holistic approach

Parkinson’s and depression: It’s not all in your mind

Depression may be common among PwPs, but it's not a sign of weakness

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

Scottish university reveals multimillion-pound Parkinson’s research partnership

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s. Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition. The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development. Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together. “This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

Parkinson’s may originate in the gut, says new study

A new study, published in medical journal ‘Neuron’, has found evidence to suggest that Parkinson’s may originate in the gut. As part of the study, researchers at Johns Hopkins University School of Medicine, US, injected abnormally folded alpha-synuclein – a protein closely connected to the development of Parkinson’s – into the gut of over 100 mice. After one month the misfolded protein had spread to areas of the brain, with researchers saying the animals’ symptoms closely mirrored the condition in humans. The results follow on from a study in Sweden in 2017, when a team of researchers at the Karolinska Institutet found similar results. Ted Dawson, professor of neurology at Johns Hopkins University and co-author of the research said: “It supports and really provides the first experimental evidence that Parkinson’s disease can start in the gut and go up the vagus nerve.”

Acupuncture may alleviate Parkinson’s symptoms

A study conducted by researchers in South Korea has found that acupuncture may help alleviate motor symptoms of Parkinson’s. The study – published in science journal ‘Frontiers in Aging Neuroscience’ – collected data from 42 existing trials testing the effects of acupuncture on different mouse models of Parkinson’s disease. A total of 40 studies showed that acupuncture increased levels of tyrosine hydroxylase – an enzyme in the brain which is part of the dopamine-producing process. Although there was no evidence to suggest acupuncture can induce changes in dopamine levels, results suggested that acupuncture may help alleviate motor symptoms in mice. Discussing their findings, the researchers commented: “Acupuncture treatment potentially protected [dopamine] neurons through various beneficial mechanisms. “Nevertheless, resolving the low quality of studies and further research investigating the efficacy of different acupuncture treatment methods in Parkinson’s disease rodent models will be needed.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Parkinson’s and animal testing: the case against

Do we have the right to test Parkinson’s medications on animals?

Age, smoking and lack of fitness increase risk of Parkinson’s

Special reports

Special reports

Special reports

Parkinson’s and animal testing: the case against

Do we have the right to test Parkinson’s medications on animals?

Age, smoking and lack of fitness increase risk of Parkinson’s

Parkinson’s drugs may lead to compulsive behaviours such as gambling

A single head injury could increase risk of Parkinson’s

sponsored article

STEP – The lived experience of Parkinson’s disease

Parkinson’s prevalence expected to increase by 18% in next seven years

Neurological disorders – including Parkinson’s – are leading source of disability globally

£16,000 a year: the hidden price of Parkinson’s

Muhammad Ali’s death “has raised Parkinson’s awareness”

How close are we to a Parkinson’s breakthrough? Three experts have their say

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Are we too focused on the search for a Parkinson’s cure?

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

“Brain Surgery Live is a modern medical miracle the public deserved to see”

The future generation of advanced therapies for Parkinson’s

Neurologists should be ‘guides not gods’ – Part 2

Parkinson’s and depression: It’s not all in your mind

Neurologists should be ‘guides not gods’ – Part 1

{categories}

{title}

Scottish university reveals multimillion-pound Parkinson’s research partnership

Parkinson’s may originate in the gut, says new study

Acupuncture may alleviate Parkinson’s symptoms

{title}

Subscribe

Sign in